Navigation Links
Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
Date:10/16/2007

CHICAGO, Oct. 16 /PRNewswire/ -- The Preimplantation Genetic Diagnosis International Society (PGDIS) is releasing a statement in response to a Practice Committee Opinion issued today by the American Society for Reproductive Medicine (ASRM).

The rationale for determining chromosomal status in transferring normal embryos is unassailable. More than 50% of embryos created in the lab from In Vitro Fertilization (IVF) are genetically abnormal - this is the de novo. However, the practice committee of ASRM has released an opinion statement regarding the practice of this screening approach during IVF.

Although the desired randomized trials have not been possible in North America because of lack of governmental funding, careful analysis and abundant data support that in experienced hands preimplantation genetic screening (PGS) is unequivocally beneficial in patients suffering from translocations, repeated spontaneous abortions, and often in advanced maternal age.

It is the opinion of PGDIS as the organization consisting of international experts in this field (embryologists, geneticists and reproductive endocrinologists) that the ASRM opinions have taken into consideration neither contemporary literature nor facts that could have been provided by embryologists, geneticists and laboratories responsible for over 90 percent of these tests worldwide.

A beneficial effect requires experienced embryologists and geneticists who can obtain blastomeres and analyze single cells in optimal fashion. Considerable expertise is required.

"Couples should be informed that this is a valuable test in selected cases," says Joe Leigh Simpson, MD and President of PGDIS. "This is however a demanding test. There are only about 15-20 centers in the US that have sufficient expertise to perform this test. Patients should be referred to these highly experienced centers."

PGDIS has an active educational program and offers workshops to train scientists in the requisite techniques. For more information on PGDIS, go to http://www.pgdis.org. PGDIS holds open international meetings, the next one which is April 25-27 in Barcelona, Spain.

About PGDIS:

PGDIS coordinates research, education and training in preimplantation genetic diagnosis (PGD), requiring a close collaboration of obstetricians, fertility specialists, embryologists and human geneticists, to insure safety and accuracy of PGD and its application into clinical practice for improvement of genetic practices and reproductive medicine.

PGDIS was organized in October 2002 and inaugurated during the 5th International Symposium on Preimplantation Genetics, Antalya, Turkey, June 5-7, 2003.

Founding Members of PGDIS are the participants of the 4th International Symposium on Preimplantation Genetics, Limassol, Cyprus, 2002; and 5th International Symposium on Preimplantation Genetics, Antalia, Turkey, 2003.

The official Journal of PGDIS is Reproductive BioMedicine Online, which has recently published many papers in this field.


'/>"/>
SOURCE The Preimplantation Genetic Diagnosis InternationalSociety (PGDIS)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
3. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
4. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
5. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
6. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
7. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
8. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
9. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
10. Myriad Genetics Presents Tumor Origin Technology at AACR
11. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 Research and Markets has announced ... report to their offering. ... The global travel vaccines market to grow at a ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the sales of various vaccines ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Ophthalmic Lasers ... report, "Australia Ophthalmic Lasers Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segements - Excimer Lasers, Femtosecond Lasers and YAG Lasers. ... shares data for each of these market segements, and ...
(Date:12/8/2016)... KEY FINDINGS The global medical ... Various reasons for growth of the medical lifting sling ... chronic diseases, high recovery cost of injuries and government ... lifting sling refers to an assistive device that helps ... connect to the lift and hold the patient. It ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... 08, 2016 , ... STAT courier is pleased to announce that due to ... they are expanding their presence in Dallas. One of the most exciting parts for ... jobs to the Dallas and Forth Worth market. STAT takes pride in treating their ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the ... Series B led by Canvas Ventures . Other investors include Nokia Growth Partners ... mobile platform to serve more consumers who are managing chronic conditions or ...
Breaking Medicine News(10 mins):